Operating Income (Loss) in USD of CV Sciences, Inc. from Q2 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CV Sciences, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2012 to Q3 2025.
  • CV Sciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$275K, a 19.4% increase year-over-year.
  • CV Sciences, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$1.04M, a 57.2% increase year-over-year.
  • CV Sciences, Inc. annual Operating Income (Loss) for 2024 was -$2.19M, a 165% decline from 2023.
  • CV Sciences, Inc. annual Operating Income (Loss) for 2023 was $3.36M.
  • CV Sciences, Inc. annual Operating Income (Loss) for 2022 was -$6.85M, a 62.9% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

CV Sciences, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1.04M -$275K +$66K +19.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$1.11M -$131K +$452K +77.5% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$1.56M $11K +$631K 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$2.19M -$646K +$243K +27.3% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 -$2.43M -$341K +$96K +22% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$2.53M -$583K +$493K +45.8% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$3.02M -$620K -$6.38M -111% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $3.36M -$889K +$1.24M +58.2% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 $2.12M -$437K +$455K +51% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $1.67M -$1.08M +$1.24M +53.5% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $430K $5.76M +$7.28M 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$6.85M -$2.13M +$6.72M +76% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 -$13.6M -$892K +$2.09M +70.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$15.7M -$2.32M +$1.2M +34% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$16.8M -$1.52M +$1.6M +51.3% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$18.4M -$8.84M +$621K +6.56% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$19.1M -$2.98M +$171K +5.43% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$19.2M -$3.51M +$1.15M +24.6% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$20.4M -$3.11M +$2.21M +41.5% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$22.6M -$9.46M -$2.12M -28.9% 01 Oct 2020 31 Dec 2020 10-K 04 Apr 2022
Q3 2020 -$20.5M -$3.15M -$1.38M -77.7% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$19.1M -$4.66M -$5.91M -471% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$13.2M -$5.32M +$4.06M +43.3% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$17.2M -$7.34M -$10.1M -366% 01 Oct 2019 31 Dec 2019 10-K 19 Mar 2021
Q3 2019 -$7.14M -$1.77M -$5.3M -150% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$1.84M $1.25M -$2.04M -62% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 $201K -$9.38M -$10M -1504% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 $10.2M $2.76M +$2.62M +1937% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $7.63M $3.53M +$4.01M 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 $3.62M $3.3M +$4.16M 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$538K $668K +$4.32M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$4.86M $135K +$8.36M 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 -$13.2M -$482K +$1.1M +69.5% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 -$14.3M -$860K +$1.2M +58.3% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 -$15.5M -$3.65M -$2.45M -203% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 -$13.1M -$8.23M -$2.6M -46.2% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018
Q3 2016 -$10.5M -$1.58M -$678K -75.1% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017
Q2 2016 -$9.8M -$2.06M -$67.4K -3.38% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$9.73M -$1.21M +$1.48M +55.1% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$11.2M -$5.63M +$3.1M +35.6% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$14.3M -$902K -$412K -84% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 -$13.9M -$2M -$2.13M -1613% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 -$11.8M -$2.69M -$3.22M -602% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$8.55M -$8.73M -$7.43M -574% 01 Oct 2014 31 Dec 2014 10-K 14 Apr 2016
Q3 2014 -$1.12M -$490K +$186K +27.5% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 -$1.3M $132K +$460K 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$1.76M $535K -$147K -21.5% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$1.62M -$1.3M 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$676K -$667K -7520% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$328K -$316K -2786% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $683K 01 Jan 2013 31 Mar 2013 10-Q/A 21 May 2014
Q3 2012 -$8.88K 01 Jul 2012 30 Sep 2012 10-Q/A 24 Apr 2014
Q2 2012 -$11.4K 01 Apr 2012 30 Jun 2012 10-Q/A 24 Apr 2014

CV Sciences, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.19M -$5.55M -165% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $3.36M +$10.2M 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 -$6.85M +$11.6M +62.9% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 -$18.4M +$4.15M +18.4% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$22.6M -$5.35M -31% 01 Jan 2020 31 Dec 2020 10-K 04 Apr 2022
2019 -$17.2M -$27.5M -268% 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2021
2018 $10.2M +$15.1M 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$4.86M +$8.21M +62.8% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019
2016 -$13.1M -$1.86M -16.6% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2018
2015 -$11.2M -$2.66M -31.1% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$8.55M -$6.94M -429% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016
2013 -$1.62M -$1.57M -3660% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$43K 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.